Merck & Co. EBITDA per Share 2011-2026 | MRK

Annual EBITDA per Share Merck & Co.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.22	0.83	0.72	0.72	0.62	0.66	6.26	5.19	4.43	4.17	5.01	4.71	5.01	5.57	5.39

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.26	0.62	3.37

Quarterly EBITDA per Share Merck & Co.

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	0.2	-	-	0.2	-	-	0.18	-	0.55	-	0.17	-	0.45	-	0.15	-	0.48	0.32	0.32	-	1.06	0.73	0.35	-	1.32	0.9	0.42	-	1.29	0.86	0.43	-	1.55	1.12	0.56	-	1.71	1.15	0.58	-	1.78	1.2	0.6	-	1.72	1.12	0.55	-	1.75	1.18	0.59	-	1.81	1.19	0.59

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.81	0.15	0.841

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
ACADIA Pharmaceuticals ACAD	1.4	$ 22.56	2.13 %	$ 3.74 B	USA
Acorda Therapeutics ACOR	-188	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-6.85	-	-	$ 86.2 M	USA
argenx SE ARGX	-6.83	$ 785.07	2.57 %	$ 25 B	Niderland
I-Mab IMAB	0.08	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Genfit SA GNFT	-2.24	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-0.23	-	-13.47 %	$ 169 M	France
Akebia Therapeutics AKBA	0.1	$ 1.43	3.62 %	$ 368 M	USA
Midatech Pharma plc MTP	-0.09	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Allakos ALLK	-2.19	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	4.25	$ 327.25	2.42 %	$ 42.9 B	USA
AlloVir ALVR	-3.02	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-3.2	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	-0.77	-	-	$ 8.42 M	USA
Alterity Therapeutics Limited ATHE	-1.68	$ 3.9	3.7 %	$ 9.38 B	Australia
Autolus Therapeutics plc AUTL	-0.99	$ 1.49	9.56 %	$ 397 M	Britain
AVROBIO AVRO	0.24	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	-5.96	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	3.68	$ 20.4	-0.87 %	$ 954 M	USA
Aquestive Therapeutics AQST	-0.66	$ 4.18	1.21 %	$ 447 M	USA
Ayala Pharmaceuticals AYLA	-2.42	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-0.39	$ 2.66	3.5 %	$ 16.7 M	USA
AstraZeneca PLC AZN	0.74	-	-	$ 96.9 B	Britain
Brainstorm Cell Therapeutics BCLI	-1.05	-	-2.5 %	$ 5.88 M	USA
Arcutis Biotherapeutics ARQT	-0.09	$ 24.61	5.76 %	$ 3.13 B	USA
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
BeiGene, Ltd. BGNE	0.42	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	-0.08	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
AgeX Therapeutics AGE	-2.35	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
Cabaletta Bio CABA	-1.7	$ 3.09	0.65 %	$ 310 M	USA
CymaBay Therapeutics CBAY	-0.95	-	-	$ 3.45 B	USA
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
Codiak BioSciences CDAK	-2.95	-	-55.98 %	$ 2.15 M	USA
Avid Bioservices CDMO	-0.12	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	-27.7	-	-	$ 1.41 B	USA
AIkido Pharma AIKI	-3.89	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	0.01	-	-45.71 %	$ 1.2 M	Canada
Checkpoint Therapeutics CKPT	-1.42	-	-	$ 169 M	USA
Celldex Therapeutics CLDX	-4.28	$ 32.41	3.38 %	$ 2.15 B	USA
Celsion Corporation CLSN	-6.76	-	-6.63 %	$ 13.9 M	USA
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-2.22	-	-	$ 867 M	Germany
Chimerix CMRX	-1.05	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	-2.21	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	-0.67	$ 3.88	2.11 %	$ 261 B	Britain